Chiopelas Efstathia MD New York City, NY - 10016

Chiopelas Efstathia MD is categorized under Group Health Associations in New York City, NY and active since 2007.

Chiopelas Efstathia MD was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Group Health Associations business, which does work in the B2C market, and is classified as a Group Health Associations, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Efstathia Chiopelas at the company’s single location by writing to 317 East 34th St Room 401, New York City, New York NY 10016 or by phoning (212) 726-7427. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Chiopelas Efstathia MD
Contact Person: Efstathia Chiopelas
Address: 317 East 34th St Room 401, New York City, New York 10016
Phone Number: (212) 726-7427
Website Address: mhmg.net
Annual Revenue (USD): $500.000 to $999.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Group Health Associations
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Chiopelas Efstathia MD was started in 2007 to provide professional Group Health Associations under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Efstathia Chiopelas for inquiries that concern Chiopelas Efstathia MD by calling the company number (212) 726-7427, as your correspondence is most welcome. Additionally, the physical location of the single location of Chiopelas Efstathia MD can be found at the coordinates 40.74441,-73.97489 as well as the street address 317 East 34th St Room 401 in New York City, New York 10016.

For its online presence, you may visit Chiopelas Efstathia MD’s website at mhmg.net and engage with its social media outlets through on Twitter and on Facebook.